ZENITH DRUGS LIMITED Share Price
ZENITH DRUGS LIMITED Share Price Today
As of 14 Aug 2026, ZENITH DRUGS LIMITED share price is ₹43.40. The stock opened at ₹43.40, compared to its previous close of ₹41.80. During today's trading session, ZENITH DRUGS LIMITED share price moved in the range of ₹43.40 to ₹43.40, with an average price of ₹43.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.30 and a high of ₹76.00.
ZENITH DRUGS LIMITED Returns Calculator
About ZENITH DRUGS LIMITED
Zenith Drugs Ltd is an India-based pharmaceutical company. The Company is mainly engaged in the business of manufacturing and trading of medicine. The Company offers a range of formulations in various forms, such as ORS powder, liquid oral, ointments, creams, gels and liquid externals, capsules, tablets. Its liquid oral products include Aceclofenac & Paracetamol Suspension; Albendazole Oral Suspension BP 25 mg/ml; Ambroxol Hydrochloride & Levocetirizine Dihydrochloride Syrup; Bromhexine Hydrochloride Syrup 4mg/5ml; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Cetirizine Dihydrochloride and AmbroxolHydrochloride Syrup; Chlorphenamine, Ammonium Chloride and Sodium Citrate Syrup; Chlorpheniramine Maleate Oral Solution USP 2 mg / 5 ml, and others. Its ointment products include Cetrimide Cream BP 0.5% w/w, Chloroxylenol Cream 0.8% w/w, Ciprofloxacin Cream 0.5% w/w, Ciprofloxacin with Fluocinolone & Clotrimazole Cream and others.
ZENITH DRUGS LIMITED Financial Highlights
- Revenue: ZENITH DRUGS LIMITED reported revenue of ₹133.74 crore in FY24 vs ₹115.76 crore in FY23. It showed an increase of 15.53% on a yearly basis.
- Operating Profit: ZENITH DRUGS LIMITED reported an operating profit of ₹14.74 crore in FY24 vs ₹6.66 crore in FY23. It showed an increase of 121.32% on a year-on-year basis.
- Net Profit: ZENITH DRUGS LIMITED reported a net profit of ₹9.65 crore in FY24 vs ₹4.88 crore in FY23. It showed an increase of 97.75% on a yearly basis.
| Sep 2024 | 0.42% |
|---|---|
| Mar 2025 | 0.06% |
| Sep 2025 | 0.00% |
| Mar 2026 | 0.00% |
ZENITH DRUGS LIMITED Shareholder Returns
ZENITH DRUGS LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,66,155.00 | 38.32 | 5.56 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,26,843.00 | 77.55 | 13.53 | 15.32% | 0.00 | 19.56% | 629.49 | 0.35% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,86,000.00 | 86.27 | 22.12 | 25.49% | 1.69 | 13.85% | 222.76 | 0.69% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,20,099.00 | 26.15 | 4.43 | 18.59% | 0.31 | 17.35% | 237.30 | 0.08% | 0.33 | 35.38 |
| Cipla | 1,18,027.00 | 35.18 | 3.43 | 11.27% | 0.00 | 14.95% | 423.36 | 0.89% | 0.45 | 43.52 |
| Lupin | 1,03,549.00 | 18.62 | 4.61 | 23.76% | 0.04 | 24.88% | 659.05 | 0.79% | 0.57 | 129.18 |
| Mankind Pharma | 1,00,137.00 | 48.43 | 6.14 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Dr. Reddy's Laboratories | 1,00,662.00 | 31.62 | 2.64 | 11.07% | 0.18 | 12.54% | 377.96 | 0.67% | 0.41 | 38.68 |
| Laurus Labs | 99,474.20 | 91.23 | 18.77 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Aurobindo Pharma | 96,700.60 | 26.06 | 2.55 | 9.25% | 0.19 | 11.76% | 391.14 | 0.24% | 0.38 | 41.58 |
ZENITH DRUGS LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Revenue | ₹131.62 | ₹114.52 | ₹91.66 |
| Other Income | ₹2.12 | ₹1.24 | ₹1.01 |
| Total Revenue | ₹133.74 | ₹115.76 | ₹92.67 |
| Total Expenses | ₹119.00 | ₹109.10 | ₹88.26 |
| Profit Before Tax | ₹13.44 | ₹6.66 | ₹4.41 |
| Tax | ₹3.80 | ₹1.78 | ₹1.28 |
| Profit After Tax | ₹9.65 | ₹4.88 | ₹3.13 |
| EPS - Basic | ₹5.63 | ₹122.02 | ₹78.22 |
| EPS - Diluted | ₹5.63 | ₹122.02 | ₹78.22 |
Cash Flow · Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Profit before tax | ₹13.44 | ₹6.66 | ₹4.41 |
| Income before WC changes | ₹17.74 | ₹10.27 | ₹7.87 |
| Change in Assets | -₹20.88 | -₹30.50 | -₹16.97 |
| Change in Liabilities | -₹5.84 | ₹17.29 | ₹15.57 |
| Change in WC | -₹26.72 | -₹13.22 | -₹1.40 |
| Cash flow from Operations | -₹13.01 | -₹4.77 | ₹5.15 |
| Cash flow from Investing | ₹26.00 | -₹0.27 | -₹5.24 |
| Cash flow from Financing | -₹4.47 | ₹4.99 | ₹1.24 |
| Total Cash Flow | ₹8.52 | -₹0.05 | ₹1.15 |
| Cash (Start of the year) | ₹0.28 | ₹0.33 | ₹1.85 |
| Cash (End of the year) | ₹8.80 | ₹0.28 | ₹3.00 |
Balance Sheet · Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Non-Current Assets | ₹21.71 | ₹14.00 | ₹15.05 |
| Current Assets | ₹113.33 | ₹83.92 | ₹53.53 |
| Total Assets | ₹135.04 | ₹97.92 | ₹68.58 |
| Current Liabilities | ₹64.15 | ₹71.65 | ₹46.58 |
| Net Current Asset | ₹49.18 | ₹12.27 | ₹6.95 |
| Non-Current Liabilities | ₹8.56 | ₹8.53 | ₹9.90 |
| Equity Capital | ₹62.33 | ₹17.74 | ₹12.11 |
| Total Equity & Liabilities | ₹135.04 | ₹97.92 | ₹68.58 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹133.32 | ₹131.62 | ₹114.52 | ₹91.66 |
| Other Income | ₹2.61 | ₹2.12 | ₹1.24 | ₹0.95 |
| Total Revenue | ₹135.93 | ₹133.74 | ₹115.76 | ₹92.60 |
| Total Expenses | ₹126.42 | ₹118.89 | ₹109.10 | ₹88.20 |
| Profit Before Tax | ₹9.26 | ₹13.29 | ₹6.66 | ₹4.40 |
| Tax | ₹2.10 | ₹3.76 | ₹1.78 | ₹1.19 |
| Profit After Tax | ₹7.16 | ₹9.54 | ₹4.88 | ₹3.21 |
| EPS - Basic | ₹4.18 | ₹5.56 | ₹122.03 | ₹80.32 |
| EPS - Diluted | ₹4.18 | ₹5.56 | ₹122.03 | ₹80.32 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹9.51 | ₹13.29 | ₹6.66 | ₹4.40 |
| Income before WC changes | ₹15.89 | ₹17.59 | ₹10.29 | ₹7.87 |
| Change in Assets | -₹11.11 | -₹20.56 | -₹30.31 | -₹16.90 |
| Change in Liabilities | -₹4.49 | -₹5.88 | ₹17.58 | ₹15.18 |
| Change in WC | -₹15.60 | -₹26.44 | -₹12.73 | -₹1.72 |
| Cash flow from Operations | -₹5.47 | -₹15.84 | -₹4.27 | ₹4.91 |
| Cash flow from Investing | -₹31.41 | -₹5.33 | -₹2.05 | -₹3.04 |
| Cash flow from Financing | ₹28.39 | ₹29.72 | ₹6.30 | -₹0.83 |
| Total Cash Flow | -₹8.48 | ₹8.55 | -₹0.01 | ₹1.04 |
| Cash (Start of the year) | ₹8.74 | ₹0.20 | ₹0.21 | ₹1.85 |
| Cash (End of the year) | ₹0.26 | ₹8.74 | ₹0.20 | ₹2.89 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹46.30 | ₹21.34 | ₹13.14 | ₹12.40 |
| Current Assets | ₹115.18 | ₹112.84 | ₹84.08 | ₹53.79 |
| Total Assets | ₹161.48 | ₹134.17 | ₹97.22 | ₹66.18 |
| Current Liabilities | ₹79.30 | ₹64.10 | ₹71.65 | ₹45.53 |
| Net Current Asset | ₹35.87 | ₹48.73 | ₹12.43 | ₹8.26 |
| Non-Current Liabilities | ₹12.80 | ₹7.85 | ₹7.84 | ₹7.81 |
| Equity Capital | ₹69.38 | ₹62.22 | ₹17.73 | ₹12.85 |
| Total Equity & Liabilities | ₹161.48 | ₹134.17 | ₹97.22 | ₹66.18 |
| 13 Aug | 0L |
|---|---|
| 12 Aug | 0L |
| 11 Aug | 0L |
| 10 Aug | 1L |
| 7 Aug | 0L |
| Average | 0L |
Popular Stocks
ZENITH DRUGS LIMITED Share Price FAQs
What is ZENITH DRUGS LIMITED share price today?
ZENITH DRUGS LIMITED share price is ₹43.40 as on 13 Aug, 2026, 14:28 IST.
How much is the Mutual Fund shareholding in ZENITH DRUGS LIMITED shares?
The Mutual Fund Shareholding in ZENITH DRUGS LIMITED was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of ZENITH DRUGS LIMITED shares ?
The 52-week high and low of ZENITH DRUGS LIMITED share is ₹76.00 and ₹33.30 as of 13 Aug, 2026.
What is the market cap of ZENITH DRUGS LIMITED?
The market capitalisation of ZENITH DRUGS LIMITED is ₹107.52 Crores as on 13 Aug, 2026.
What are the stock symbols of ZENITH DRUGS LIMITED?
The stock symbol of ZENITH DRUGS LIMITED is ZENITHDRUG on the NSE, , and the ISIN is INE0QWN01013.
What was yesterday's closing price for ZENITH DRUGS LIMITED shares ?
ZENITH DRUGS LIMITED shares closed yesterday at ₹41.80 on NSE
How to buy ZENITH DRUGS LIMITED shares?
To buy ZENITH DRUGS LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy ZENITH DRUGS LIMITED shares on Holidays?
No, shares of ZENITH DRUGS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell ZENITH DRUGS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of ZENITH DRUGS LIMITED?
The PE and PB ratio of ZENITH DRUGS LIMITED is 11.22 and 1.73 respectively, as on 13 Aug, 2026, 14:28 IST.